Drugs / VXA-BYW.10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02547792 | Oct 2015 → Nov 2016 | — | Vaxart | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VXA-BYW.10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02547792 ↗ |
| Modality | Vaccine | “oral adenoviral-vector based Influenza B vaccine” NCT02547792 ↗ |
| Route | Oral | “Enteric coated tablet for oral delivery” NCT02547792 ↗ |